Functional properties of the human ventral mesencephalic neural stem cell line hVM1.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 20122925)

Published in Exp Neurol on February 01, 2010

Authors

Jan Tønnesen1, Emma Gonzalez Seiz, Milagros Ramos, Olle Lindvall, Alberto Martinez-Serrano, Merab Kokaia

Author Affiliations

1: Experimental Epilepsy Group, Wallenberg Neuroscience Center, Lund University Hospital, 221 84, Lund, Sweden.

Articles by these authors

Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med (2002) 10.10

Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med (2008) 6.90

Inflammation is detrimental for neurogenesis in adult brain. Proc Natl Acad Sci U S A (2003) 5.09

Direct conversion of human fibroblasts to dopaminergic neurons. Proc Natl Acad Sci U S A (2011) 4.81

Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat Med (2004) 2.98

Persistent production of neurons from adult brain stem cells during recovery after stroke. Stem Cells (2005) 2.88

Forebrain ependymal cells are Notch-dependent and generate neuroblasts and astrocytes after stroke. Nat Neurosci (2009) 2.74

New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell (2008) 2.61

Research in motion: the enigma of Parkinson's disease pathology spread. Nat Rev Neurosci (2008) 2.51

Environment matters: synaptic properties of neurons born in the epileptic adult brain develop to reduce excitability. Neuron (2006) 2.38

Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions. Cell Rep (2012) 2.31

Improving outcome after stroke: overcoming the translational roadblock. Cerebrovasc Dis (2008) 2.26

Optogenetic control of epileptiform activity. Proc Natl Acad Sci U S A (2009) 2.24

Factors affecting the clinical outcome after neural transplantation in Parkinson's disease. Brain (2005) 2.06

Long-term neuroblast migration along blood vessels in an area with transient angiogenesis and increased vascularization after stroke. Stroke (2007) 1.98

Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis. J Neurosci (2006) 1.91

Long-term accumulation of microglia with proneurogenic phenotype concomitant with persistent neurogenesis in adult subventricular zone after stroke. Glia (2009) 1.86

Neurogenesis after ischaemic brain insults. Curr Opin Neurobiol (2003) 1.80

Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants. Sci Transl Med (2010) 1.78

Stroke research priorities for the next decade--A representative view of the European scientific community. Cerebrovasc Dis (2006) 1.75

Dyskinesias following neural transplantation in Parkinson's disease. Nat Neurosci (2002) 1.74

Cross-talk between neural stem cells and immune cells: the key to better brain repair? Nat Neurosci (2012) 1.55

Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease. Mov Disord (2010) 1.47

Long-term assessment of striatal dopamine transporters in Parkinsonian patients with intrastriatal embryonic mesencephalic grafts. Eur J Nucl Med Mol Imaging (2006) 1.46

Reduced N-acetylaspartate levels in mice lacking aralar, a brain- and muscle-type mitochondrial aspartate-glutamate carrier. J Biol Chem (2005) 1.42

[QFT utility in health personal]. Rev Chilena Infectol (2014) 1.39

Stroke-induced neurogenesis in aged brain. Stroke (2005) 1.38

Neural stem and progenitor cells retain their potential for proliferation and differentiation into functional neurons despite lower number in aged brain. J Neurosci (2009) 1.37

The endocannabinoid anandamide inhibits neuronal progenitor cell differentiation through attenuation of the Rap1/B-Raf/ERK pathway. J Biol Chem (2002) 1.36

Bimodal viral vectors and in vivo imaging reveal the fate of human neural stem cells in experimental glioma model. J Neurosci (2008) 1.36

Inflammation regulates functional integration of neurons born in adult brain. J Neurosci (2008) 1.35

Human-induced pluripotent stem cells form functional neurons and improve recovery after grafting in stroke-damaged brain. Stem Cells (2012) 1.34

Forebrain acetylcholine regulates adult hippocampal neurogenesis and learning. Neurobiol Aging (2005) 1.31

Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice. J Clin Invest (2008) 1.29

MANF is widely expressed in mammalian tissues and differently regulated after ischemic and epileptic insults in rodent brain. Mol Cell Neurosci (2008) 1.29

Regulation of stem cell therapies under attack in Europe: for whom the bell tolls. EMBO J (2013) 1.28

Cell number and timing of transplantation determine survival of human neural stem cell grafts in stroke-damaged rat brain. J Cereb Blood Flow Metab (2010) 1.24

Emerging concepts in neural stem cell research: autologous repair and cell-based disease modelling. Lancet Neurol (2009) 1.23

Intracerebral infusion of glial cell line-derived neurotrophic factor promotes striatal neurogenesis after stroke in adult rats. Stroke (2006) 1.18

Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio. Mov Disord (2011) 1.14

Efficient induction of functional neurons from adult human fibroblasts. Cell Cycle (2011) 1.12

Health-related quality of life in multiple system atrophy. Mov Disord (2006) 1.11

Ultrastructural and antigenic properties of neural stem cells and their progeny in adult rat subventricular zone. Glia (2009) 1.11

Grafted neural stem cells develop into functional pyramidal neurons and integrate into host cortical circuitry. Proc Natl Acad Sci U S A (2002) 1.11

Regulation of stroke-induced neurogenesis in adult brain--recent scientific progress. Cereb Cortex (2006) 1.10

Inhibition of microglial activation protects hippocampal neurogenesis and improves cognitive deficits in a transgenic mouse model for Alzheimer's disease. Neurodegener Dis (2012) 1.10

Human fetal cortical and striatal neural stem cells generate region-specific neurons in vitro and differentiate extensively to neurons after intrastriatal transplantation in neonatal rats. J Neurosci Res (2006) 1.10

Human induced pluripotent stem cell-derived cortical neurons integrate in stroke-injured cortex and improve functional recovery. Brain (2013) 1.09

Long-term neuronal replacement in adult rat hippocampus after status epilepticus despite chronic inflammation. Eur J Neurosci (2006) 1.07

Clinical application of stem cell therapy in Parkinson's disease. BMC Med (2012) 1.07

Caspase-mediated death of newly formed neurons in the adult rat dentate gyrus following status epilepticus. Eur J Neurosci (2002) 1.07

Functional integration of grafted neural stem cell-derived dopaminergic neurons monitored by optogenetics in an in vitro Parkinson model. PLoS One (2011) 1.06

Suppression of stroke-induced progenitor proliferation in adult subventricular zone by tumor necrosis factor receptor 1. J Cereb Blood Flow Metab (2008) 1.05

Abeta immunotherapy protects morphology and survival of adult-born neurons in doubly transgenic APP/PS1 mice. J Neurosci (2009) 1.05

Essential role of aralar in the transduction of small Ca2+ signals to neuronal mitochondria. J Biol Chem (2005) 1.05

TNF-alpha antibody infusion impairs survival of stroke-generated neuroblasts in adult rat brain. Exp Neurol (2005) 1.03

Neuronal apoptosis after brief and prolonged seizures. Prog Brain Res (2002) 1.03

Status epilepticus severity influences the long-term outcome of neurogenesis in the adult dentate gyrus. Neurobiol Dis (2004) 1.02

Grafted human neural stem cells enhance several steps of endogenous neurogenesis and improve behavioral recovery after middle cerebral artery occlusion in rats. Neurobiol Dis (2012) 1.02

Serotonin neuron loss and nonmotor symptoms continue in Parkinson's patients treated with dopamine grafts. Sci Transl Med (2012) 1.02

Seizure suppression by GDNF gene therapy in animal models of epilepsy. Mol Ther (2007) 1.01

Role of aralar, the mitochondrial transporter of aspartate-glutamate, in brain N-acetylaspartate formation and Ca(2+) signaling in neuronal mitochondria. J Neurosci Res (2007) 0.99

Global optogenetic activation of inhibitory interneurons during epileptiform activity. J Neurosci (2014) 0.99

Pyruvate protection against beta-amyloid-induced neuronal death: role of mitochondrial redox state. J Neurosci Res (2003) 0.98

Death mechanisms in status epilepticus-generated neurons and effects of additional seizures on their survival. Neurobiol Dis (2003) 0.98

Angels and demons: neurotrophic factors and epilepsy. Trends Pharmacol Sci (2006) 0.97

Adeno-associated viral vector-induced overexpression of neuropeptide Y Y2 receptors in the hippocampus suppresses seizures. Brain (2010) 0.95

Signs of degeneration in 12-22-year old grafts of mesencephalic dopamine neurons in patients with Parkinson's disease. J Parkinsons Dis (2011) 0.95

Embryonic stem cell-derived neural stem cells fuse with microglia and mature neurons. Stem Cells (2012) 0.94

Long-term molecular and cellular stability of human neural stem cell lines. Exp Cell Res (2004) 0.94

Health status measurement in Parkinson's disease: validity of the PDQ-39 and Nottingham Health Profile. Mov Disord (2003) 0.94

Quantitative analysis of the generation of different striatal neuronal subtypes in the adult brain following excitotoxic injury. Exp Neurol (2005) 0.93

How might novel technologies such as optogenetics lead to better treatments in epilepsy? Adv Exp Med Biol (2014) 0.91

Novel approaches to epilepsy treatment. Epilepsia (2012) 0.91

Functional integration of new hippocampal neurons following insults to the adult brain is determined by characteristics of pathological environment. Exp Neurol (2011) 0.90

Decreased expression of brain-derived neurotrophic factor in BDNF(+/-) mice is associated with enhanced recovery of motor performance and increased neuroblast number following experimental stroke. J Neurosci Res (2006) 0.90

Hippocampal Noradrenaline and Serotonin Release over 24 Hours as Measured by the Dialysis Technique in Freely Moving Rats: Correlation to Behavioural Activity State, Effect of Handling and Tail-Pinch. Eur J Neurosci (1989) 0.90

Meteorin is a chemokinetic factor in neuroblast migration and promotes stroke-induced striatal neurogenesis. J Cereb Blood Flow Metab (2011) 0.89

Intraventricular infusion of TrkB-Fc fusion protein promotes ischemia-induced neurogenesis in adult rat dentate gyrus. Stroke (2003) 0.89

Functional properties and synaptic integration of genetically labelled dopaminergic neurons in intrastriatal grafts. Eur J Neurosci (2005) 0.89

Cometin is a novel neurotrophic factor that promotes neurite outgrowth and neuroblast migration in vitro and supports survival of spiral ganglion neurons in vivo. Exp Neurol (2011) 0.89

Elevated GDNF levels following viral vector-mediated gene transfer can increase neuronal death after stroke in rats. Neurobiol Dis (2003) 0.88

Epilepsy therapy development: technical and methodologic issues in studies with animal models. Epilepsia (2013) 0.88

Deep brain stimulation in Parkinson's disease following fetal nigral transplantation. Mov Disord (2008) 0.88

NPY gene transfer in the hippocampus attenuates synaptic plasticity and learning. Hippocampus (2008) 0.88

In vitro and in vivo enhanced generation of human A9 dopamine neurons from neural stem cells by Bcl-XL. J Biol Chem (2010) 0.88

Suppression of limbic motor seizures by electrical stimulation in thalamic reticular nucleus. Exp Neurol (2003) 0.86

Differential suppression of seizures via Y2 and Y5 neuropeptide Y receptors. Neurobiol Dis (2005) 0.86

Hippocampal NPY gene transfer attenuates seizures without affecting epilepsy-induced impairment of LTP. Exp Neurol (2008) 0.86

Electrophysiological investigations of synaptic connectivity between host and graft neurons. Prog Brain Res (2012) 0.86

Cell replacement therapy: helping the brain to repair itself. NeuroRx (2004) 0.85